Travere Therapeutics’ $275 Million Convertible Senior Notes Offering

Laura Testa
Tagged:

Latham & Watkins represented the underwriters in the offering.Travere Therapeutics, Inc. executed its offering of US$275 million aggregate principal amount of 2.25% convertible senior notes due 2029. The…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

…

This content is for Standard 1 Year members only.
Login Join Now